Stage III Laryngeal Cancer AJCC v8

specific

Stage I includes: T1, N0, M0. T1: Supraglottis: Tumor is limited to one subsite of supraglottis with normal vocal cord mobility. Glottis: Tumor is limited to the vocal cord(s) (may involve anterior or posterior commissure) with normal mobility. Subglottis: Tumor is limited to the subglottis. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.)

71

Centers

137

Active Trials

Cancer Funding

Top Centers for Stage III Laryngeal Cancer AJCC v8(71)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
High-Volume Research Center
72.9
2
NCI Comprehensive
High-Volume Research Center
71.9
3
NCI Comprehensive
High-Volume Research Center
71.9
469.7
5
NCI Comprehensive
Active Research Program
69.7
6
NCI Comprehensive
Active Research Program
69.7
7
NCI Comprehensive
Active Research Program
69.7
8
Active Research Program
69.7
9
NCI Comprehensive
Active Research Program
63.4
10
NCI Comprehensive
Active Research Program
63.4
11
NCI Comprehensive
Active Research Program
63.4
12
NCI Comprehensive
Active Research Program
63.4
13
NCI Clinical
Active Research Program
63.4
14
Active Research Program
63.4
15
NCI Clinical
Active Research Program
63.4
16
NCI Comprehensive
Active Research Program
63.4
17
NCI Comprehensive
Active Research Program
63.4
18
Active Research Program
63.4
19
Active Research Program
63.4
20
NCI Comprehensive
Active Research Program
63.4
21
Active Research Program
63.4
22
Active Research Program
63.4
23
Active Research Program
63.4
24
NCI Comprehensive
Active Research Program
53.9
25
NCI Comprehensive
Active Research Program
53.9
26
NCI Comprehensive
Active Research Program
53.9
27
NCI Comprehensive
Active Research Program
53.9
28
NCI Comprehensive
Active Research Program
53.9
29
NCI Comprehensive
Active Research Program
53.9
30
NCI Comprehensive
Active Research Program
53.9
31
NCI Comprehensive
Active Research Program
53.9
32
Active Research Program
53.9
33
NCI Comprehensive
Active Research Program
53.9
34
Rutgers Cancer InstituteNew Brunswick, NJ
NCI Comprehensive
Active Research Program
53.9
35
NCI Clinical
Active Research Program
53.9
36
Active Research Program
53.9
37
Active Research Program
53.9
38
Active Research Program
53.9
39
NCI Comprehensive
Active Research Program
40.9
40
NCI Comprehensive
Active Research Program
40.9
41
NCI Comprehensive
Active Research Program
40.9
42
NCI Comprehensive
Active Research Program
40.9
43
NCI Comprehensive
Active Research Program
40.9
44
NCI Comprehensive
Active Research Program
40.9
45
NCI Comprehensive
Active Research Program
40.9
46
Masonic Cancer CenterMinneapolis, MN
NCI Comprehensive
Active Research Program
40.9
47
NCI Comprehensive
Active Research Program
40.9
48
NCI Comprehensive
Active Research Program
40.9
49
NCI Comprehensive
Active Research Program
40.9
50
NCI Comprehensive
Active Research Program
40.9
51
NCI Comprehensive
Active Research Program
40.9
52
Cedars-Sinai CancerLos Angeles, CA
Active Research Program
40.9
53
NCI Comprehensive
Active Research Program
40.9
54
NCI Comprehensive
Active Research Program
40.9
55
NCI Comprehensive
Active Research Program
40.9
56
Fox Chase Cancer CenterPhiladelphia, PA
NCI Comprehensive
Active Research Program
40.9
5740.9
58
Active Research Program
40.9
59
Active Research Program
40.9
60
NCI Basic_laboratory
Active Research Program
40.9
61
Active Research Program
40.9
62
Active Research Program
40.9
63
Active Research Program
40.9
64
Active Research Program
40.9
65
NCI Comprehensive
30.4
66
NCI Comprehensive
30.4
67
NCI Comprehensive
30.4
68
NCI Comprehensive
30.4
6930.4
7030.4
7130.4

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →